Authors:
Alo, PL
Visca, P
Botti, C
Galati, GM
Sebastiani, V
Andreano, T
Tondo, UD
Pizer, ES
Citation: Pl. Alo et al., Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue, AM J CLIN P, 116(1), 2001, pp. 129-134
Authors:
Guadagni, F
Ferroni, P
Carlini, S
Mariotti, S
Spila, A
Aloe, S
D'Alessandro, R
Carone, MD
Cicchetti, A
Ricciotti, A
Venturo, I
Perri, P
Di Filippo, F
Cognetti, F
Botti, C
Roselli, M
Citation: F. Guadagni et al., A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study, CLIN CANC R, 7(8), 2001, pp. 2357-2362
Authors:
Vecchione, A
Zanesi, N
Trombetta, G
French, D
Visca, P
Pisani, T
Botti, C
Vecchione, A
Croce, CM
Mancini, R
Citation: A. Vecchione et al., Cervical dysplasia, ploidy, and human papillomavirus status correlate withloss of FHIT expression, CLIN CANC R, 7(5), 2001, pp. 1306-1312
Authors:
Nerini-Molteni, S
Seregni, E
Crippa, F
Maffioli, L
Botti, C
Bombardieri, E
Citation: S. Nerini-molteni et al., Uptake of tritiated thymidine, deoxyglucose and methionine in three lung cancer cell lines: Deoxyglucose uptake mirrors tritiated thymidine uptake, TUMOR BIOL, 22(2), 2001, pp. 92-96
Authors:
D'Alessandro, R
Roselli, M
Ferroni, P
Mariotti, S
Spila, A
Aloe, S
Carone, MD
Abbolito, MR
Carlini, S
Perri, P
Ricciotti, A
Botti, C
Conti, F
Vici, P
Chiappetta, NR
Cognetti, F
Buonomo, O
Guadagni, F
Citation: R. D'Alessandro et al., Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer, BREAST CANC, 68(1), 2001, pp. 9-19
Authors:
Botti, C
Pescatore, B
Mottolese, M
Sciarretta, F
Greco, C
Di Filippo, F
Gandolfo, GM
Cavaliere, F
Bovani, R
Varanese, A
Cianciulli, AM
Citation: C. Botti et al., Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: An interphase cytogenetic study, J AM COLL S, 190(5), 2000, pp. 530-539
Citation: C. Botti et P. Comba, Ethical considerations concerning the regulation of human exposure to electromagnetic fields, EPIDEMIOLOG, 11(2), 2000, pp. 225-227
Authors:
Cavaliere, F
Di Filippo, F
Botti, C
Cosimelli, M
Giannarelli, D
Aloe, L
Arcuri, E
Aromatario, C
Consolo, S
Callopoli, A
Laurenzi, L
Tedesco, M
Di Angelo, P
Giunta, S
Cavaliere, R
Citation: F. Cavaliere et al., Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis, EUR J SUR O, 26(5), 2000, pp. 486-491
Authors:
Botti, C
Seregni, E
Menard, S
Collini, P
Tagliabue, E
Campiglio, M
Vergani, B
Ghirelli, C
Aiello, P
Pilotti, S
Bombardieri, E
Citation: C. Botti et al., Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer, INT J B MAR, 15(4), 2000, pp. 312-320
Authors:
Mattioli, S
Seregni, E
Caperna, L
Botti, C
Savelli, G
Bombardieri, E
Citation: S. Mattioli et al., BTA-TRAK combined with urinary cytology is a reliable urinary indicator ofrecurrent transitional cell carcinoma (TCC) of the bladder, INT J B MAR, 15(3), 2000, pp. 219-225
Authors:
Mottolese, M
Benevolo, M
Del Monte, G
Buglioni, S
Papaldo, P
Nistico, C
Di Filippo, F
Vasselli, S
Vici, P
Botti, C
Citation: M. Mottolese et al., Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy, J CANC RES, 126(12), 2000, pp. 722-729
Authors:
Di Filippo, F
Rossi, CR
Vaglini, M
Azzarelli, A
Anza, M
Santinami, M
Lise, M
Cavaliere, F
Giannarelli, D
Quagliuolo, V
Vecchiato, A
Deraco, M
Garinei, R
Foletto, M
Botti, C
Cavaliere, R
Citation: F. Di Filippo et al., Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: Results of a phase I study, J IMMUNOTH, 22(5), 1999, pp. 407-414
Authors:
Visca, P
Alo, PL
Del Nonno, F
Botti, C
Trombetta, G
Marandino, F
Filippi, S
Di Tondo, U
Donnorso, RP
Citation: P. Visca et al., Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa, CLIN CANC R, 5(12), 1999, pp. 4111-4118
Authors:
Cavaliere, E
Di Filippo, F
Cosimelli, M
Aloe, L
Arcuri, E
Anza, M
Callopoli, A
Di Lauro, L
Morace, E
Botti, C
Natoli, S
Tedesco, M
Giunta, S
Cavaliere, R
Citation: E. Cavaliere et al., The integrated treatment of peritoneal carcinomatosis. A preliminary experience, J EXP CL C, 18(2), 1999, pp. 151-158
Authors:
Alo, PL
Visca, P
Trombetta, G
Mangoni, A
Lenti, L
Monaco, S
Botti, C
Serpieri, DE
Di Tondo, U
Citation: Pl. Alo et al., Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas, TUMORI, 85(1), 1999, pp. 35-40
Authors:
Molteni, SN
Seregni, E
Botti, C
Martinetti, A
Ferrari, L
Crippa, F
Bombardieri, E
Citation: Sn. Molteni et al., The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-medronate incorporation, ANTICANC R, 19(1A), 1999, pp. 255-259
Authors:
Milella, M
Nistico, C
Ferraresi, V
Vaccaro, A
Fabi, A
D'Ottavio, AM
Botti, C
Giannarelli, D
Lopez, M
Cortesi, E
Foggi, CM
Antimi, M
Terzoli, E
Cognetti, F
Papaldo, P
Citation: M. Milella et al., Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women, BREAST CANC, 55(3), 1999, pp. 259-266